{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:18:14Z","timestamp":1790803094777,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jmii.2025.08.023","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T06:35:12Z","timestamp":1756362912000},"page":"117-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Levofloxacin is as effective as trimethoprim-sulfamethoxazole for the treatment of pertussis: A prospective observational study"],"prefix":"10.1016","volume":"59","author":[{"given":"Chuning","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailing","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiehao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingliang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqiu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jmii.2025.08.023_bib1","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.vaccine.2015.10.136","article-title":"Pertussis vaccines: WHO position paper, August 2015--Recommendations","volume":"34","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.jmii.2025.08.023_bib2","series-title":"Pertussis reported cases and incidence","year":"2024"},{"issue":"2","key":"10.1016\/j.jmii.2025.08.023_bib3","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4161\/21645515.2014.988549","article-title":"Characterization of co-purified acellular pertussis vaccines","volume":"11","author":"Xu","year":"2015","journal-title":"Hum Vaccines Immunother"},{"issue":"5","key":"10.1016\/j.jmii.2025.08.023_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106289","article-title":"Global resurgence of pertussis: a perspective from China","volume":"89","author":"Liu","year":"2024","journal-title":"J Infect"},{"issue":"5 Suppl","key":"10.1016\/j.jmii.2025.08.023_bib6","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/01.inf.0000160707.44131.ae","article-title":"The global pertussis initiative: process overview","volume":"24","author":"Plotkin","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"10.1016\/j.jmii.2025.08.023_bib8","article-title":"Macrolide resistance in Bordetella pertussis: current situation and future challenges","volume":"11","author":"Ivaska","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jmii.2025.08.023_bib9","article-title":"Emerging macrolide resistance in Bordetella pertussis in mainland China: findings and warning from the global pertussis initiative","volume":"8","author":"Feng","year":"2021","journal-title":"Lancet Reg Health West Pac"},{"issue":"1","key":"10.1016\/j.jmii.2025.08.023_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106835","article-title":"Domination of an emerging erythromycin-resistant ptxP3 Bordetella pertussis clone in Shanghai, China","volume":"62","author":"Cai","year":"2023","journal-title":"Int J Antimicrob Agents"},{"issue":"20","key":"10.1016\/j.jmii.2025.08.023_bib11","doi-asserted-by":"crossref","first-page":"437","DOI":"10.46234\/ccdcw2024.085","article-title":"Emergence of erythromycin-resistant and pertactin- and filamentous hemagglutinin-deficient Bordetella pertussis strains \u2014 beijing, China, 2022\u20132023","volume":"6","author":"Zhou","year":"2024","journal-title":"China CDC Wkly"},{"issue":"3","key":"10.1016\/j.jmii.2025.08.023_bib12","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1128\/CMR.00083-15","article-title":"Pertussis: microbiology, disease, treatment, and prevention","volume":"29","author":"Kilgore","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jmii.2025.08.023_bib13","series-title":"Red Book: 2021-2024 Report of the Committee on Infectious Diseases","year":"2021"},{"issue":"15","key":"10.1016\/j.jmii.2025.08.023_bib14","first-page":"1258","article-title":"[Guidelines for diagnosis and management and prevention of pertussis of China (2024)]","volume":"104","year":"2024","journal-title":"Zhonghua Yixue Zazhi"},{"issue":"1","key":"10.1016\/j.jmii.2025.08.023_bib15","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1542\/peds.2012-1619","article-title":"Trends in adverse reactions to trimethoprim-sulfamethoxazole","volume":"131","author":"Goldman","year":"2013","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.jmii.2025.08.023_bib16","doi-asserted-by":"crossref","first-page":"282","DOI":"10.21101\/cejph.a4948","article-title":"Trends in the minimum inhibitory concentrations of erythromycin, clarithromycin, azithromycin, ciprofloxacin, and trimethoprim\/sulfamethoxazole for strains of Bordetella pertussis isolated in the Czech Republic in 1967-2015","volume":"25","author":"Jakubu","year":"2017","journal-title":"Cent Eur J Public Health"},{"issue":"11","key":"10.1016\/j.jmii.2025.08.023_bib17","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1128\/AAC.34.11.2287","article-title":"In vitro susceptibilities of Bordetella pertussis and bordetella Parapertussis to seven fluoroquinolones","volume":"34","author":"Hoppe","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.jmii.2025.08.023_bib18","article-title":"Pharmacotherapy for Bordetella pertussis infection. I. A synthesis of laboratory sciences","volume":"57","author":"Cimolai","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2025.08.023_bib19","series-title":"State Administration of Traditional Chinese Medicine of the People's Republic of China, Medical Department of the People's Liberation Army General Logistics Department. [Guideline Principles for Clinical Use of Antibiotic (2015)]","year":"2015"},{"issue":"5","key":"10.1016\/j.jmii.2025.08.023_bib20","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2706","article-title":"The use of systemic and topical fluoroquinolones","volume":"138","author":"Jackson","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.jmii.2025.08.023_bib21","unstructured":"CLSI. Performance Standards for Antimicrobial Susceptibility Testing. M100. 34th ed. Clinical and Laboratory Standards Institute, Wayne, PA."},{"issue":"2","key":"10.1016\/j.jmii.2025.08.023_bib22","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s12098-024-05334-4","article-title":"Skin Lesions in children with pertussis treated with sulfamethoxazole-trimethoprim","volume":"92","author":"Yuan","year":"2024","journal-title":"Indian J Pediatr"},{"issue":"3","key":"10.1016\/j.jmii.2025.08.023_bib23","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/jac\/dkg145","article-title":"In vitro activity of fluoroquinolones against erythromycin-susceptible and -resistant Bordetella pertussis","volume":"51","author":"Bourgeois","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2025.08.023_bib24","series-title":"Guidance on the management of cases of pertussis in England during the re-emergence of pertussis in 2024","year":"2024"},{"key":"10.1016\/j.jmii.2025.08.023_bib25","series-title":"Pertussis: CDNA National Guidelines for Public Health Units, Version 4.0","year":"2024"},{"key":"10.1016\/j.jmii.2025.08.023_bib26","series-title":"The Selection and Use of Essential Medicines 2023: Executive Summary of the Report of the 24th WHO Expert Committee on the Selection and Use of Essential Medicines","article-title":"World Health Organization Model List of Essential Medicines for children \u2013 9th list, 2023","author":"Web Annex","year":"2023"},{"issue":"20","key":"10.1016\/j.jmii.2025.08.023_bib27","first-page":"2096","article-title":"[Guidelines for diagnosis and treatment of Mycoplasma Pneumoniae pneumonia in children (2023)]","volume":"3","year":"2023","journal-title":"Chin J Ration Drug Use"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118225001811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118225001811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T04:06:35Z","timestamp":1769832395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118225001811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1684118225001811"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2025.08.023","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levofloxacin is as effective as trimethoprim-sulfamethoxazole for the treatment of pertussis: A prospective observational study","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2025.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}